The clinical efficacy of kanamycin for Mycobacterium avium complex disease

Yakugaku Zasshi

Volumn 128, Issue 3, 2008, Pages 451-460

  Suzuki, Ayumi ^a   Nishimura, Takahiro ^b   Ohtawa, Syuichi ^b   Mikami, Jiro ^b   Kurashima, Atuyuki ^b   Saito, Masaki ^a   Mita, Mitsuo ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOKYO NATIONAL HOSPITAL   (Japan)

Author keywords

Clinical effect; Kanamycin; Mycobacterium avium complex disease; Retrospective study; Time kill assay

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HUMAN; HYPOACUSIS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; RELAPSE; RETROSPECTIVE STUDY; SPUTUM; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VISUAL DISORDER;

AGED; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; KANAMYCIN; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RETROSPECTIVE STUDIES; RIFAMPIN;

EID: 40449110005     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.451     Document Type: Article

References (21)

1. Sakatani M., Kekkaku, 74, 377-384 (1999).
2. Wallace Jr. R. J., Brown B. A., Griffith D. E., Girard W. M., Murphy D. T., Onyi G. O., Steingrube V. A., Mazurek G. H., Am. J. Respir. Crit. Care Med., 149, 1335-1341 (1994).
3. Dautzenberg B., Piperno D., Diot P., Truffot-Pernot C., Chauvin J. P., Chest, 107, 1035-1040 (1995).
4. American Thoracic Society Medical Section of The American Lung Association, Am. J. Respir. Crit. Care Med., 156, S1-S25 (1997).
5. Wallace Jr. R. J., Brown B. A., Griffith D. E., Girard W. M., Murphy D. T., Am. Respir. Crit. Care Med., 153, 1766-1772 (1996).
6. The Japanese Society for Tuberculosis, Kekkaku, 78, 569-572 (2003).
7. Kobashi Y., Okimoto N., Matsushima T., Shigetou E., Kuraoka T., Takeyama H., Eda R., Yano S., Kobayashi K., Ohnishi T., Mori K., Ueda Y.,Moritaka T., Nishimura K., Abe T., Kekkaku, 77, 435-441 (2002).
8. Kobashi Y., Yoshida K., Miyashita N., Niki Y., Oka M., J. Infect. Chemother., 12, 195-202 (2006).
9. Kobashi Y., Matsushima T., Oka M., Respir. Med., 101, 130-138 (2007).
10. Kuze F., Am. Rev. Respir. Dis., 129, 453-459 (1984).
11. Sakurai N., Kuze F., Kekkaku, 62, 7-12 (1987).
12. Kuze F., Kurasawa T., Bando K., Lee Y., Maekawa N., Rev. Infect. Dis., 3, 885-897 (1981).
13. Takeuchi T., Hikiji T., Nitta K., Yamazaki S., Abe S., Takayama H., Umezawa H., J. Antibiot. (Tokyo), 10, 107-114 (1957).
14. Tanaka E., Kimoto T., Tsuyuguchi K., Watanabe I., Matsumoto H., Niimi A., Suzuki K., Murayama T., Amitani R., Kuze F., Am. Respir. Crit. Care Med., 160, 866-872 (1999).
15. Taga S., Ogawa K., Nakagawa T., Tano M., Kekkaku, 80, 1-7 (2005).
16. Sano K., Sato K., Tomioka H., Jpn. J. Chemother., 49, 649-652 (2001).
17. Bakker-Woudenberg I. A., van Vianen W., van Soolingen D., Verbrugh H. A., van Agtmael M. A., Antimicrob. Agents Chemother., 49, 2387-2398 (2005).
18. Peloquin C. A., Berning S. E., Nitta A. T., Shimone P. M., Goble M., Huitt G. A., Iseman M. D., Cook J. L., Curran-Everett D., Clin. Infect. Dis., 38, 1538-1544 (2004).
19. De Jager P., van Altena R., Int. J. Tuberc. Lung Dis., 6, 622-627 (2002).
20. Kawazu Y., Sagara S., Miura M., Kuniyoshi M., Yoneda R., Kurashima A., Haga T., Kiso To Rinsyo, 19, 401-412 (1985).
21. Griffith D. E., Aksamit T., Brown-Elliott B. A., Catanzaro A., Daley C., Gordin F., Holland S. M., Horsburgh R., Huitt G., Iademarco M. F., Iseman M., Olivier K., Ruoss S., von Reyn C. F.,Wallace R. J., Winthrop K.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America, Am. J. Respir. Crit. Care Med., 175, 367-416 (2007).